is recognized by most attaching clinical isolates. However, wild-type isolates can express adhesins with several different receptor specificities. Bioassays do not permit separate analysis of each receptor specificity, since the target cells contain multiple potentially receptor-active molecules. In this study, bacterial adhesins were analyzed by using receptors immobilized onto latex beads in one of two ways. In one way, di-and trisaccharides were covalently linked via a spacer arm to latex beads coupled with bovine serum albumin. In the other way, receptor-active glycolipids were coated onto the bovine serum albumin-latex beads. The latex beads were subsequently used for agglutination by using type strains with known receptor specificity. The composition was optimized regarding receptor structure and size of latex beads. Gala1l-4GalIp was as active as the trisaccharide derivative Galal-4Galll->3glucose or Galal->4GaIfl-,-3glucosamine. Among the natural glycolipids tested, globotetraosylceramide was the most active. Subsequently, the sensitivity and specificity of the Galkl->4GalIp-latex and globotetraosylceramide-latex reagents were compared for 733 E. coli urinary isolates. Hemagglutination of human erythrocytes was used as the positive standard. No significant difference in the specificity or sensitivity of the latex reagents was found; the sensitivity ranged from 86%, when isolates agglutinating human erythrocytes of blood groups P1 and p were included, to 93%, when those isolates agglutinating erythrocytes of blood group p were excluded. These reagents provide tools for bacterial identification in patients with urinary tract infection.
Bacterial attachment contributes to microbial persistence at mucosal surfaces and may be a prerequisite for infection (1) . The mechanism(s) of binding has been most extensively characterized for uropathogenic Escherichia coli (11) (12) (13) (14) (15) . Bacterial surface proteins, adhesins, bind glycoconjugate receptors on the target cells. The globoseries of glycolipids, with Galal1->4Galp [galactose-a(1-->4)galactosep] as the minimal natural receptor, are recognized by most attaching uropathogenic E. coli cells (13) . The receptor function of the globoseries of glycolipids has been demonstrated in several ways. Bacterial binding is restricted to cells containing the receptors. Thus, cells from humans of blood group p which lack or synthesize small amounts of the globoseries of glycolipids, do not bind bacteria with Galal->4Gal specificity. Glycolipid extracts from their cells do not inhibit adherence. In contrast, E. coli cells attach to cells from humans of blood groups P1 and P2, and attachment is inhibited by glycolipid fractions from their uroepithelial cells (12, 13) , as well as by purified or synthetic receptors (11) . Addition of receptor to a previously unreactive cell or to a solid phase (2, 13, 20) conferred the ability to bind bacteria.
The characterization of adhesins on clinical isolates has previously been based on bioassays, e.g., attachment to uroepithelial cells or hemagglutination (7, 11) . However, the evaluation is complicated by the facts that adhesins specific for several receptors may be coexpressed and that the receptor composition of the target cells varies between individuals, tissues, and species (15, 16 solid-phase assays (7, 14, 14a, 20) . The present study presents the composition, specificity, and sensitivity of latex agglutination tests detecting bacterial binding to globoseries glycolipid receptors. This test is available for general use.
MATERIALS AND METHODS Bacteria. The study was performed in two steps. First, isolates with known receptor specificity were used to identify receptor structures optimal for the latex agglutination assay. Those strains used were wild-type strains of E. coli, numbers 1146, 1212, 1224, 1195, and 12505, which were urinary isolates from among the 733 strains used (see below) with specificity for the globoseries of glycolipid receptors, as measured by reactivity with human blood group P, but not p, erythrocytes. E. coli 36692 was shown, e.g., by thin-layer chromatogram binding assay (2) , to express adhesins for the globoseries of glycolipid receptors (13, 19) . A series of mutants and transformants with genetically manipulated adhesins was also used. E. coli Hu824 and Hu742 were mutants of the wild-type pyelonephritis isolate GR12. From the parent strain, Hu824 retained adhesins specific for the globoseries glycolipid receptors; Hu742 retained adhesins binding mannosides (18) . The mutants were cultured on tryptic soy agar (BBL Microbiology Systems, Cockeysville, Md.). The transformant 506MR had received a chromosomal DNA fragment, pap, coding for expression of fimbriae and ability to bind Galal-*4Gal, (10, 19) , cloned into pACYC184. The Glycoconjugates. The glycoconjugates used in the present study are listed in Table 1 . The glycolipids were purified by alkaline degradation, dialysis, and ion-exchange and silicic acid chromatography of the native and acetylated derivatives. The known glycolipid structures were confirmed by mass spectrometry, nuclear magnetic resonance spectroscopy, and degradative methods (3, 13, 15) . Galca1-*4Galp-OH and Gala1->4Galp-O-ethyl were synthesized as previously described (5, 6) .
Preparation of latex reagents with synthetic receptor analogs. Polystyrene latex beads (0.81-, 2.0-, and 6.4-ptm diameters; Seragen Diagnostics, Indianapolis, Ind.) were modified to poly(p-aminostyrene), followed by coupling to bovine serum albumin (BSA; Kabi-Vitrum, Stockholm, Sweden).
Spacer arm glycosides of Galx1 ->4Galp-O and lactosel-Oof the type saccharide 0-O-CH2-CH2-S-CH2-CH2-COOmethyl were coupled to the modified particles by the neoglycoprotein synthesis procedure described previously (6 Enzyme-linked immunosorbent assay. The concentration of oligosaccharide coupled to the latex beads was estimated in a competitive enzyme-linked immunosorbent assay. Microtiter plates (Nunc, Roskilde, Denmark) were coated with each oligosaccharide coupled to BSA (1 mg/ml suspended in PBS, 0.1 ml per well). Monoclonal antibodies specific for each oligosaccharide, obtained from Biocarb, Lund, Sweden, were diluted 1:10 to 1:10,000 in PBS-2% Tween 80 (Kebo Laboratories, Stockholm, Sweden), and 0.1 ml was added to each well. After incubation for 4 h at 37°C, the plates were washed, and alkaline phosphatase-conjugated goat anti-mouse immunoglobulin was added (Orion, Helsinki, Finland). The antibody activity was determined as the A405 after 100 min of incubation with substrate. In parallel, the antibody dilutions were preincubated with oligosaccharide-BSA-latex beads. After centrifugation, the antibody activity remaining in the supernatant was quantitated as described above. The receptor concentration was deduced by comparing the inhibition with that obtained after absorption with known amounts of free oligosaccharide.
Hemagglutination. Erythrocyte suspensions (3%) in PBS or PBS-0.1 mM a-methyl mannoside were prepared from freshly drawn, washed, heparinized human (blood group AP1 or Ap) or guinea pig blood. For hemagglutination, 20 pi of the bacterial suspension (1010 bacteria per ml) and 20 pl of the erythrocyte suspension were mixed on a microscope slide. After gentle tilting for 2 min, the agglutination was read with the naked eye and graded -, +, ++, or + + + (7, 15) .
The hemagglutination pattern of each strain was described with two Table 2) . None of the strains showed nonspecific reactions with the latex beads, latex-BSA, or latex-BSA-lactose.
The receptor activity of the four glycoconjugates globotetraosylceramide, Galcx1->4Galp, Galal->4Gal,1->3Glc, and Gall-->4Gal31---*3GlcNAc were compared ( Fig. 1) (Glc, glucose; GlcNAc, N-acetylglucosamine). The mutant and transformant specific for Galt1-*4Galp, as well as wild-type strains with known specificity for the globoseries of gly- tion was greater for globo-latex than for Galotl->4Gal-latex (P < 0.01). The reactivity with erythrocytes and latex beads was analyzed pairwise for each isolate. The results are shown in Fig. 2A and B. Strains reactive with p erythrocytes were excluded, since their hemagglutination was explained by specificity for receptors other than Galal->4Gal. Highly significant correlations were obtained between human Pl erythrocytes and globo-latex reactivity and human P1 erythrocytes and Gall-->4Gal-latex reactivity (P < 0.001). Human erythrocytes had a higher frequency of positive reactions than did the latex reagents; 18 strains reactive with human Pl erythrocytes did not react with globo-latex, and 19 strains did not react with Galal->4Gal-latex. The number of isolates reacting with the latex reagents but not with human erythrocytes was nine for both globo-latex and Galal->4Gal-latex.
The pairwise comparison of the reactivity with the globolatex and GalLl-*4Gal-latex reagents is shown in Fig. 3 . Thirteen strains reacted only with globo-latex; none reacted only with the Gall-->4Gal-latex beads.
The specificity and sensitivity of the latex reagents were calculated by using reactivity with human Pl erythrocytes as the 100% control. By using all of the 733 E. coli isolates, a sensitivity of 89.6 and 89.3% and a specificity of 97.6% was shown for globo-latex and Galaol-4Gal-latex. Excluding the strains reactive with p erythrocytes, the corresponding values were 93.5 and 93.1 for sensitivity and 97.6 for specificity. Galal-*4Gal had lower activity, that the disaccharide coupled in a ,1 position Galal->4Galactosep-O-ethyl had better activity, and that the intact tetrasaccharide from globotetraosylceramide, GalNAcp1->3Galal->4GalBl->4Glc, had the best inhibitory activity. It was proposed that, although Galal->4Galp is the minimal structure common to naturally receptor-active molecules, it is not optimal in its soluble form. Such a difference in activity was not observed when the di-and trisaccharides were coupled to latex beads. This suggests that the molecule is presented to the bacteria more efficiently when coupled to a solid phase. In addition, it is likely that the ongoing studies of the exact mechanism of binding will result in the synthesis of receptor analogs with higher affinity than the natural receptors, which then can be used for construction of the next generation of reagents.
The composition of the latex agglutination test was varied regarding the concentration and multivalency of the receptors, the buffer systems, and the particle sizes. Increasing the concentration of Gala1-*4Galp bound to latex did not improve the sensitivity of the assay. Multivalency has been demonstrated as a major determinant of ligand-receptor interactions. The initial recognition is followed by recruitment of receptors in the fluid membrane and successive multiple interactions resulting in, e.g., phagocytosis (18) press). Uropathogenic E. coli may be an exception in that multivalent receptors, e.g., poly-L-lysine highly derivatized with Galal->4Gal, were not more efficient as inhibitors in bioassays than was Galal-+4Gal3-O-ethyl (unpublished observation).
The sensitivity and specificity of globo-latex and Galal-*4Galo-latex were highly similar. However, a limited number of strains were shown to bind globo-latex but not Galal->4GalB-latex. Still, they probably were specific for Galatl->4GalB, since agglutination was inhibited by this oligosaccharide (8 
